Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2009-04-21Clinical Trial Update: A Naturalistic Prospective Study of Treatment Effectiveness for Attention-Deficit/Hyperactivity Disorder (ADHD)
The clinical trial investigating treatment effectiveness for attention-deficit/hyperactivity disorder has been withdrawn.
-
FDA approval · 2009-04-16FDA Approved: METHYLPHENIDATE HYDROCHLORIDE CD — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental NDA for Methylphenidate Hydrochloride CD (generic from Lannett) to authorize its continued marketing as a methyl…
-
CLINICAL_TRIALS trial_result · 2009-04-07Clinical Trial Update: Efficacy, Safety, and Tolerability of Ambien (Zolpidem) in the Treatment of Children Ages 6 to 17 With Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia [Phase 3]
A Phase 3 trial evaluated zolpidem (Ambien) for ADHD-associated insomnia in children aged 6 to 17, assessing efficacy, safety, and tolerabil…
-
CLINICAL_TRIALS trial_result · 2009-03-30Clinical Trial Update: A Study of Dex-methylphenidate Extended Release in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 4]
Phase 4 trial evaluating dexmethylphenidate extended-release for attention-deficit/hyperactivity disorder in children aged 6 to 12 has compl…
-
CLINICAL_TRIALS trial_result · 2009-03-06Clinical Trial Update: Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA [Phase 4]
Phase 4 trial update characterizes dermal reactions in children with ADHD treated with the Daytrana methylphenidate patch. Results were post…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2009-02-16Clinical Trial Update: Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)
This update assesses the reliability and validity of the MINI-KID, a structured interview for diagnosing psychiatric disorders in children a…
-
CLINICAL_TRIALS trial_result · 2009-02-12Clinical Trial Update: Genetic Polymorphism and OROS-Methylphenidate Treatment in Attention Deficit Hyperactivity Disorder(ADHD) [Phase 4]
Phase 4 study evaluating the influence of genetic polymorphisms on response to osmotic-release methylphenidate in attention-deficit/hyperact…
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Pharmacokinetics of Two Extended-Release Formulations of Methylphenidate in Children With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 1, Phase 2]
Phase 1/2 pharmacokinetic study evaluating two extended-release formulations of methylphenidate in children with ADHD has been completed.
-
CLINICAL_TRIALS research · 2009-01-21Clinical Trial Update: Evaluation of the Effect of rTMS on Attention in Adults Diagnosed With Attention-Deficit Hyperactivity Disorder (ADHD) [NA]
A clinical trial evaluating whether repetitive transcranial magnetic stimulation (rTMS) affects attention in adults with attention deficit h…
-
CLINICAL_TRIALS trial_result · 2009-01-16Clinical Trial Update: Stimulant Drug Treatment of Attention-Deficit Hyperactivity Disorder (AD/HD), Inattentive Type [NA]
Completed clinical trial update examining stimulant therapy for ADHD, inattentive type, with no specific stimulant identified in the report.
-
CLINICAL_TRIALS research · 2009-01-16Clinical Trial Update: Characterization of Executive Functions and Patterns of Eye Movements in Children With Developmental Disabilities
Clinical trial update describing methods to characterize executive functions and eye movement patterns in children with developmental disabi…
-
FDA approval · 2009-01-14FDA Approved: CONCERTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved Janssen's supplemental application for CONCERTA (methylphenidate hydrochloride), updating labeling per the submission.
-
CLINICAL_TRIALS trial_result · 2008-12-11Clinical Trial Update: Effect of Vyvanse on Sleep in Children Aged 6-12 Years With Attention Deficit Hyperactivity Disorder (ADHD) [NA]
This entry reports the completion of a clinical trial evaluating the effect of Vyvanse (lisdexamfetamine) on sleep in children aged 6-12 wit…
-
FDA approval · 2008-11-12FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Prasco Laboratories to market a generic combination of amphetamine salts (dextroamphetamine sacc…
-
CLINICAL_TRIALS trial_result · 2008-10-31Clinical Trial Update: Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODD [Phase 3]
Phase 3 trial comparing atomoxetine to placebo in children and adolescents with ADHD and oppositional defiant disorder has completed.
-
FDA approval · 2008-10-17FDA Approved: FOCALIN XR — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for FOCALIN XR submitted by Sandoz Inc, related to dexmethylphenidate hydrochloride (brand: FOCA…
-
FDA approval · 2008-08-26FDA Approved: METHYLPHENIDATE HYDROCHLORIDE CD — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for methylphenidate hydrochloride CD from Lannett Company, Inc. The product is a controlled-delivery…
-
FDA approval · 2008-08-11FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Teva's generic combination of four amphetamine salts: dextroamphetamine saccharate, amphetamine …
-
CLINICAL_TRIALS trial_result · 2008-08-07Clinical Trial Update: Aripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolar Disorder and ADHD [Phase 4]
This Phase 4 clinical trial update reports the completion of a study evaluating the combination of aripiprazole and methylphenidate in child…
-
CLINICAL_TRIALS trial_result · 2008-08-07Clinical Trial Update: Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD) [NA]
Clinical trial update on aripiprazole in children and adolescents with bipolar disorder and ADHD. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2008-07-30Clinical Trial Update: NeuroLex EEG-Based ADHD Assessment Aid, Pivotal Study
A pivotal clinical trial evaluating the NeuroLex EEG-based ADHD assessment aid for diagnosing Attention-Deficit/Hyperactivity Disorder has b…
-
FDA approval · 2008-07-23FDA Approved: STRATTERA — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for STRATTERA (atomoxetine hydrochloride) filed by Eli Lilly, resulting in updated labeling.
-
CLINICAL_TRIALS trial_result · 2008-07-15Clinical Trial Update: Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar [Phase 2]
Phase 2 trial evaluating atomoxetine alone or in combination with buspirone for adults with Attention-Deficit/Hyperactivity Disorder has com…
-
CLINICAL_TRIALS trial_result · 2008-07-03Clinical Trial Update: Study of Eyes and Attention Deficit (SEAD)
The SEAD study by Ohio State University investigating eye-related issues in people with ADHD and binocular vision conditions has completed.
-
FDA approval · 2008-06-27FDA Approved: CONCERTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for CONCERTA (methylphenidate hydrochloride) submitted by Janssen Pharmaceuticals, Inc.